PAR-20-292 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 3

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity	NOT-CA-22-001	NCI , NHLBI	Nov 4, 2021	Nov 6, 2024	R01, R03, R21, P01
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention	NOT-CA-21-121	NCI	Oct 4, 2021	Sep 8, 2024	K22, K08, R15, R01, R21, K99/R00
Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules	NOT-CA-21-101	NCI	Aug 16, 2021	Jan 8, 2024	R01, R15, R21

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)